Peptok
peptides profiled research articles
Growth Hormone Secretagogue

MK-677 (Ibutamoren)

Formula: C27H36N4O5S

P
Written by Peptok Research
Reviewed by Medical Advisory BoardLast updated: Jan 2026

Quick Stats

Evidence Strength3/10 (Low)

Based on number and quality of indexed studies

Community Popularity10/10 (High)

Based on search volume and community interest

Legal Status

⚖️ Not FDA-approved

Type

Growth Hormone Secretagogue

Route

Oral

Half-life

24 hours

Medical Disclaimer

This content is for informational and research purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before making decisions about peptide use or any medical treatment. Individual results may vary.

Overview

MK-677 (Ibutamoren) is an orally-active growth hormone secretagogue, meaning it stimulates the pituitary gland to release growth hormone. Unlike many peptides, it does *not* require injection. MK-677 mimics the action of ghrelin, a hormone that regulates appetite, sleep, and growth hormone release.

Quick Summary

  • 🧬
    What it is:MK-677 (Ibutamoren) is an orally-active growth hormone secretagogue, meaning it stimulates the pituitary gland to release growth hormone.
  • 🎯
    Primary use:Growth Hormone Secretagogue applications — see benefits section for details.
  • 📊
    Evidence level:Preliminary — Mostly anecdotal or very early-stage research (3 indexed papers)
  • Bottom line:Very early research phase. Approach with appropriate caution; long-term safety is unknown.

MK-677, also known as Ibutamoren or Nutrobal, is a unique compound: it's a growth hormone secretagogue that can be taken orally. Most peptides require injection to avoid being broken down in the digestive system. MK-677 bypasses this, offering a convenient alternative for those seeking to increase growth hormone levels. It's also banned in equine sports as a doping agent, highlighting its potential performance-enhancing effects [3, 4].

While often grouped with peptides, MK-677 is technically a non-peptide molecule. It mimics the action of ghrelin, a naturally occurring hormone in the body. This mimicry allows it to stimulate growth hormone release without the need for injections or other more complex delivery methods.

How MK-677 (Ibutamoren) Works

MK-677 primarily works by acting as a ghrelin receptor agonist. Ghrelin is a hormone produced in the stomach that plays a crucial role in regulating appetite, sleep, and growth hormone secretion. By binding to and activating the ghrelin receptor (also known as the growth hormone secretagogue receptor, or GHS-R1A), MK-677 stimulates the release of growth hormone from the pituitary gland.

This activation also influences the hypothalamic-pituitary-somatotropic axis, a complex hormonal pathway that controls growth and metabolism. When MK-677 activates the ghrelin receptor, it triggers a cascade of events that ultimately lead to increased production and release of growth hormone. This, in turn, stimulates the liver to produce insulin-like growth factor 1 (IGF-1), a hormone that promotes growth and tissue repair.

Unlike some other growth hormone releasing peptides, MK-677 doesn't directly affect levels of cortisol. This can be an advantage, as elevated cortisol can have negative effects on muscle growth and overall health. By selectively targeting the ghrelin receptor, MK-677 can increase growth hormone and IGF-1 levels without significantly impacting cortisol production.

What the Research Actually Shows

Here's a breakdown of what the research suggests about the potential benefits of MK-677:

  • Increased Growth Hormone and IGF-1 Levels:

    • Evidence Grade: Strong
    • MK-677 is proven to significantly increase both growth hormone and IGF-1 levels. This is its primary mechanism of action and the most well-supported effect. Several studies have demonstrated this effect in both humans and animals. A review article in Sex Medicine Reviews confirms the efficacy of growth hormone secretagogues, including MK-677, in raising growth hormone levels [1].
  • Improved Body Composition:

    • Evidence Grade: Preliminary
    • Some studies suggest that MK-677 may improve body composition by increasing muscle mass and reducing body fat. However, the evidence is not conclusive. A case report published in Experimental Physiology showed that the combined use of MK-677 and LGD-4033 (a SARM) impacted body composition [2]. More research is needed to determine the specific effects of MK-677 on body composition when used alone.
  • Appetite Stimulation:

    • Evidence Grade: Moderate
    • As a ghrelin receptor agonist, MK-677 is known to increase appetite. This can be beneficial for individuals who are underweight or have difficulty eating enough, but it can also be a drawback for those trying to manage their weight. This effect is a direct consequence of its mechanism of action.
  • Sleep Improvement:

    • Evidence Grade: Anecdotal/Preliminary
    • Some users report improved sleep quality while taking MK-677. Ghrelin plays a role in sleep regulation, so this effect is plausible. However, there is limited scientific evidence to support this claim. More research is needed to determine the impact of MK-677 on sleep.
  • Cognitive Function:

    • Evidence Grade: None
    • There is no reliable evidence that MK-677 improves cognitive function. In fact, one clinical trial investigating MK-677 as a treatment for Alzheimer's disease found no clinical benefit on the progression of Alzheimer's [5].

MK-677 (Ibutamoren) vs. Growth Hormone Secretagogue peptides

MK-677 is often compared to Growth Hormone Secretagogue peptides like CJC-1295 and Ipamorelin. While all these compounds aim to increase growth hormone levels, they differ significantly in their mechanisms and administration.

  • Mechanism: MK-677 is a ghrelin receptor agonist, mimicking ghrelin to stimulate growth hormone release. CJC-1295 and Ipamorelin, on the other hand, are growth hormone-releasing hormone (GHRH) analogs. They stimulate growth hormone release by binding to the GHRH receptor on pituitary cells.
  • Administration: MK-677 is orally active, making it convenient to take. CJC-1295 and Ipamorelin require subcutaneous injections. This difference in administration is a major factor for many users.
  • Cortisol Levels: MK-677 does not significantly impact cortisol levels. CJC-1295 can sometimes elevate cortisol and prolactin. Ipamorelin is generally considered to have a minimal impact on cortisol levels, making it a more selective growth hormone secretagogue.
  • Pulsatile vs. Sustained Release: CJC-1295 and Ipamorelin typically lead to a pulsatile release of growth hormone, mimicking the body's natural secretion patterns. MK-677 can lead to a more sustained elevation of growth hormone levels, which may or may not be desirable depending on individual goals.

In summary, MK-677 offers the convenience of oral administration and doesn't affect cortisol, but leads to sustained GH elevation. CJC-1295 and Ipamorelin require injections and have different effects on cortisol, but offer more control over the pulsatile release of growth hormone.

The Honest Limitations

While MK-677 shows promise, it's important to acknowledge its limitations:

  • Long-Term Studies: Most studies on MK-677 are relatively short-term (weeks to months). The long-term effects of chronic MK-677 use are not well-understood. More research is needed to assess the safety and efficacy of long-term use.
  • Limited Human Trials: While some human trials have been conducted, many of the studies are small or have specific populations (e.g., elderly individuals). More large-scale, randomized controlled trials (RCTs) are needed to confirm the potential benefits and risks of MK-677 in a broader population.
  • Ethical Concerns: MK-677 is banned in many sports due to its potential performance-enhancing effects. Athletes should be aware of these regulations and the potential consequences of using MK-677.
  • Individual Variability: The effects of MK-677 can vary significantly from person to person. Factors such as age, genetics, and overall health can influence the response to MK-677.
  • Metabolite Characterization: Research has characterized the metabolites of Ibutamoren in horses [6]. While this is important for doping control, it highlights the need for more comprehensive studies on human metabolism of MK-677 to fully understand its effects and potential risks.

Optimizing MK-677 Timing for Appetite Management

A common side effect of MK-677 is increased appetite, due to its ghrelin-mimicking action. To mitigate this, consider taking your daily dose of MK-677 right before bed. This strategy can help you sleep through the peak of appetite stimulation, making it easier to manage your caloric intake. You may also experience deeper sleep as an added benefit. If you're already struggling with late-night cravings, you may want to experiment with different timing. Use a peptide dosage calculator to ensure accurate dosing.

Benefits & Evidence

Increased growth hormone and IGF-1 levels

Strong Evidence

3 studies · 2 human trials

Improved sleep quality and REM sleep

Moderate Evidence

2 studies · 1 human trial

Enhanced muscle mass and strength

Moderate Evidence

1 studies · 0 human trials

Improved bone density

Preliminary

1 studies · 0 human trials

Better skin elasticity and hair growth

Preliminary

1 studies · 0 human trials

Accelerated recovery from exercise

Preliminary

1 studies · 0 human trials

Who Uses MK-677 (Ibutamoren)?

Research enthusiasts

Preliminary

Emerging therapeutic applications being studied

Biohackers

Anecdotal

Exploring optimization potential

Not recommended if:

Pregnant or nursing, history of hormone-sensitive cancers, active autoimmune conditions, or pediatric patients. Always consult a physician before starting any peptide protocol.

Dosage Guide

Protocol by Experience Level

ExperienceDoseFrequencyCycleRoute
Beginner10 mgDaily or EOD4–6 wks, 2 wks offOral
Intermediate18 mgDaily4–6 wks, 2 wks offOral
Advanced25 mgDaily (split dose)4–6 wks, 2 wks offOral

Standard Protocol

10-25 mg per day orally. Most common dose is 25 mg before bed.

Notes

Taking before bed may minimize appetite increase side effects. Start at 10 mg to assess tolerance. Blood glucose should be monitored regularly.

Route

Oral

Half-life

24 hours

Molecular Weight

528.67 g/mol

Disclaimer

This information is for educational purposes only. Dosage information is derived from research literature and community reports. Always consult a qualified healthcare provider before using any peptide.

What the Community Reports

Community data coming soon

We're aggregating Reddit discussions for MK-677 (Ibutamoren).

Safety Profile

Regulatory Status

Not FDA-approved. Available as research chemical in many countries. Banned by WADA.

Common

  • Increased appetite (common)
  • Water retention and bloating
  • Mild lethargy

Rare

  • Numbness/tingling in hands
  • Elevated blood glucose levels

Serious

No serious adverse events reported in available literature.

Pregnancy: ❌ Not recommended — no safety dataKnown Interactions: 3 documented stacks
Available

Your Ad could be placed here.

Reach researchers and enthusiasts.

Contact Us

Research

Mechanism of Action

MK-677 is a non-peptide ghrelin receptor agonist (growth hormone secretagogue receptor, GHS-R1a). It mimics ghrelin's action to stimulate the anterior pituitary to release growth hormone in a pulsatile pattern. Unlike exogenous GH, it preserves the natural GH pulse pattern and does not suppress endogenous production. It also increases IGF-1 levels and improves nitrogen balance.

Search Volume Trend

Rank #2
12 months agoPresent
Clinical Trial1998

MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism

Journal of Clinical Endocrinology & Metabolism · Murphy MG, et al.

Clinical Trial1997

Oral administration of growth hormone (GH) releasing peptide-mimetic MK-677 stimulates the GH/insulin-like growth factor-I axis

Journal of Clinical Endocrinology & Metabolism · Chapman IM, et al.

Clinical Trial2000

Two-year effects of MK-677 on bone mineral density in adults with GH deficiency

Annals of Internal Medicine · Murphy MG, et al.

Common Stacks

Peptides frequently combined together for synergistic effects.

CJC-1295

Body Composition

Growth hormone secretagogue stack for enhanced recovery and body composition

Ipamorelin

Body Composition

Growth hormone secretagogue stack for enhanced recovery and body composition

BPC-157

Recovery & Healing

Complements systemic healing with localized tissue repair

Peptok is editorially independent. Our research profiles are evidence-based and regularly updated. Sponsored content is always clearly labeled. Read our Editorial Policy.